Literature DB >> 30047373

Ebola virus disease: 11 323 deaths later, how far have we come?

Joseph A Lewnard1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30047373     DOI: 10.1016/S0140-6736(18)31443-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The Special Pathogens Research Network: Enabling Research Readiness.

Authors:  Colleen S Kraft; Mark G Kortepeter; Bruce Gordon; Lauren M Sauer; Erica S Shenoy; Daniel P Eiras; LuAnn Larson; Jennifer A Garland; Aneesh K Mehta; Kevin Barrett; Connie S Price; Caroline Croyle; Lauren R West; Brooke Noren; Susan Kline; Christa Arguinchona; Henry Arguinchona; Jonathan D Grein; Chad Connally; Susan McLellan; George F Risi; Timothy M Uyeki; Richard T Davey; Jo Ellen Schweinle; Michelle M Schwedhelm; Melissa Harvey; Richard C Hunt; Christopher J Kratochvil
Journal:  Health Secur       Date:  2019-02-19

2.  Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells.

Authors:  Mirza S Baig; Manikandan Alagumuthu; Sajjan Rajpoot; Uzma Saqib
Journal:  Drugs R D       Date:  2020-09

Review 3.  Outbreak analytics: a developing data science for informing the response to emerging pathogens.

Authors:  Jonathan A Polonsky; Amrish Baidjoe; Zhian N Kamvar; Anne Cori; Kara Durski; W John Edmunds; Rosalind M Eggo; Sebastian Funk; Laurent Kaiser; Patrick Keating; Olivier le Polain de Waroux; Michael Marks; Paula Moraga; Oliver Morgan; Pierre Nouvellet; Ruwan Ratnayake; Chrissy H Roberts; Jimmy Whitworth; Thibaut Jombart
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

Review 4.  A review of the latest research on Mpro targeting SARS-COV inhibitors.

Authors:  Huihui Yang; Jinfei Yang
Journal:  RSC Med Chem       Date:  2021-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.